Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond). 2019;39(1):22.

PubMed  Google Scholar 

Teoh JY, Huang J, Ko WY, Lok V, Choi P, Ng CF, Sengupta S, Mostafid H, Kamat AM, Black PC, et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol. 2020;78(6):893–906.

PubMed  Google Scholar 

Tao L, Xiang YB, Wang R, Nelson HH, Gao YT, Chan KK, Yu MC, Yuan JM. Environmental tobacco smoke in relation to bladder cancer risk—the Shanghai bladder cancer study [corrected]. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3087–95.

CAS  PubMed  PubMed Central  Google Scholar 

Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC. Sex- and smoking-related bladder cancer risk. J Natl Cancer Inst. 2001;93(7):538–45.

CAS  PubMed  Google Scholar 

Janisch F, Shariat SF, Schernhammer E, Rink M, Fajkovic H. The interaction of sex and smoking on bladder cancer risks. Curr Opin Urol. 2019;29(3):249–55.

PubMed  Google Scholar 

Samanic C, Kogevinas M, Dosemeci M, Malats N, Real FX, Garcia-Closas M, Serra C, Carrato A, Garcia-Closas R, Sala M, et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and sex. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1348–54.

PubMed  Google Scholar 

Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA. Sex and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69(2):300–10.

PubMed  Google Scholar 

Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res. 2007;67(15):7540–5.

CAS  PubMed  Google Scholar 

Liu X, Jiang J, Yu C, Wang Y, Sun Y, Tang J, Chen T, Bi Y, Liu Y, Zhang ZJ. Secular trends in incidence and mortality of bladder cancer in China, 1990–2017: a joinpoint and age-period-cohort analysis. Cancer Epidemiol. 2019;61:95–103.

PubMed  Google Scholar 

Collaborators GBDD. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1160–203.

Google Scholar 

Collaborators GBDRF: Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396(10258):1223–49.

!!! INVALID CITATION !!! .

Cumberbatch MG, Rota M, Catto JW, La Vecchia C. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol. 2016;70(3):458–66.

CAS  PubMed  Google Scholar 

van Osch FH, Jochems SH, van Schooten FJ, Bryan RT, Zeegers MP. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies. Int J Epidemiol. 2016;45(3):857–70.

PubMed  Google Scholar 

Svensson J, Carstensen B, Molbak A, Christau B, Mortensen HB, Nerup J, Borch-Johnsen K. Increased risk of childhood type 1 diabetes in children born after 1985. Diabetes Care. 2002;25(12):2197–201.

PubMed  Google Scholar 

Carstensen B. Age-period-cohort models for the Lexis diagram. Stat Med. 2007;26(15):3018–45.

CAS  PubMed  Google Scholar 

Shukla VV, Weaver LJ, Singh A, Rahman A, Nakhmani A, Travers CP, Sinkey R, Arora N, Ambalavanan N, Carlo WA. Social distancing during the COVID-19 pandemic and neonatal mortality in the US. JAMA Netw Open. 2024;7(7): e2422995.

PubMed  PubMed Central  Google Scholar 

Xu W, He J, Li W, He Y, Wan H, Qin W, Chen Z. Long-short-term-memory-based deep stacked sequence-to-sequence autoencoder for health prediction of industrial workers in closed environments based on wearable devices. Sensors (Basel). 2023;23(18):7874.

PubMed  Google Scholar 

Access GBDH, Quality Collaborators. Electronic address cue, Access GBDH, Quality C: Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet 2017;390(10091):231–66.

Xie Y, Bowe B, Xian H, Balasubramanian S, Al-Aly Z. Rate of kidney function decline and risk of hospitalizations in Stage 3A CKD. Clin J Am Soc Nephrol. 2015;10(11):1946–55.

CAS  PubMed  PubMed Central  Google Scholar 

Hosseinpoor AR, Bergen N, Schlotheuber A. Promoting health equity: WHO health inequality monitoring at global and national levels. Glob Health Action. 2015;8:29034.

PubMed  Google Scholar 

Inoue-Choi M, Liao LM, Reyes-Guzman C, Hartge P, Caporaso N, Freedman ND. Association of long-term, low-intensity smoking with all-cause and cause-specific mortality in the National Institutes of Health-AARP Diet and Health Study. JAMA Intern Med. 2017;177(1):87–95.

PubMed  PubMed Central  Google Scholar 

Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234–41.

PubMed  Google Scholar 

Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology. 2003;8(1):17–21.

PubMed  Google Scholar 

Li S, Meng L, Chiolero A, Ma C, Xi B. Trends in smoking prevalence and attributable mortality in China, 1991–2011. Prev Med. 2016;93:82–7.

PubMed  PubMed Central  Google Scholar 

Wang M, Luo X, Xu S, Liu W, Ding F, Zhang X, Wang L, Liu J, Hu J, Wang W. Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013. Lancet Respir Med. 2019;7(1):35–45.

PubMed  Google Scholar 

Zi H, He SH, Leng XY, Xu XF, Huang Q, Weng H, Zhu C, Li LY, Gu JM, Li XH, et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019. Mil Med Res. 2021;8(1):60.

PubMed  PubMed Central  Google Scholar 

Yang Y, Cheng Z, Jia X, Shi N, Xia Z, Zhang W, Shi X. Mortality trends of bladder cancer in China from 1991 to 2015: an age-period-cohort analysis. Cancer Manag Res. 2019;11:3043–51.

PubMed  PubMed Central  Google Scholar 

Li HZ, Zheng RS, Du LB, Zhang SW, Zhu C, Wei WW, He J. Bladder cancer incidence, mortality and temporal trends in China. Zhonghua Zhong Liu Za Zhi. 2021;43(3):293–8.

CAS  PubMed  Google Scholar 

He H, Xie H, Chen Y, Li C, Han D, Xu F, Lyu J. Global, regional, and national burdens of bladder cancer in 2017: estimates from the 2017 global burden of disease study. BMC Public Health. 2020;20(1):1693.

PubMed  PubMed Central  Google Scholar 

Wanneveich M, Jacqmin-Gadda H, Dartigues JF, Joly P. Impact of intervention targeting risk factors on chronic disease burden. Stat Methods Med Res. 2018;27(2):414–27.

PubMed  Google Scholar 

Xiang Z, Ye Z, Ma J, Lin Y, Zhou Y. Temporal trends and projections of bladder cancer burden in China from 1990 to 2030: findings from the Global Burden of Disease Study. Clin Epidemiol. 2022;14:1305–15.

PubMed  PubMed Central  Google Scholar 

Hu TW, Zhang X, Zheng R. China has raised the tax on cigarettes: what’s next? Tob Control. 2016;25(6):609–11.

PubMed  Google Scholar 

Mackay J. China: the tipping point in tobacco control. Br Med Bull. 2016;120(1):15–25.

PubMed  Google Scholar 

Alcorn T. Winds shift for tobacco control in China. Lancet Respir Med. 2013;1(9):679–80.

PubMed  Google Scholar 

La Vecchia C, Negri E. Nutrition and bladder cancer. Cancer Causes Control. 1996;7(1):95–100.

PubMed  Google Scholar 

Fankhauser CD, Mostafid H. Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle. Curr Opin Urol. 2018;28(1):88–92.

PubMed  Google Scholar 

Kwan ML, Garren B, Nielsen ME, Tang L. Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer. Urol Oncol. 2019;37(6):380–6.

PubMed  Google Scholar 

Karimi A, Shobeiri P, Azadnajafabad S, Masinaei M, Rezaei N, Ghanbari A, Rezaei N, Rouhifard M, Shahin S, Rashidi MM, et al. A global, regional, and national survey on burden and Quality of Care Index (QCI) of bladder cancer: the global burden of disease study 1990–2019. PLoS ONE. 2022;17(10): e0275574.

CAS  PubMed  PubMed Central  Google Scholar 

Mortality GBD. Causes of Death C: Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.

Google Scholar 

Cai Q, Chen Y, Xin S, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, et al. Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030. Transl Androl Urol. 2020;9(2):153–65.

PubMed  PubMed Central  Google Scholar 

Nejatinamini S, Godley J, Minaker LM, Sajobi TT, McCormack GR, Cooke MJ, Nykiforuk CIJ, Koning L, Olstad DL. Quantifying the contribution of modifiable risk factors to socio-economic inequities in cancer morbidity and mortality: a nationally representative population-based cohort study. Int J Epidemiol. 2021;50(5):1498–511.

PubMed  Google Scholar 

Collaborators GBDTF: Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health 2024;9(10):e729–e744.